Novel motif:77
From FANTOM5_SSTAR
name: | motif77_TCCTTGG |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0071316 | cellular response to nicotine | 4.034057e-13 |
GO:0071312 | cellular response to alkaloid | 2.771362e-12 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2.226883e-11 |
GO:0033986 | response to methanol | 2.279282e-11 |
GO:0046687 | response to chromate | 2.279282e-11 |
GO:0044341 | sodium-dependent phosphate transport | 2.379760e-11 |
GO:0042790 | transcription of nuclear large rRNA transcript from RNA polymerase I promoter | 2.502136e-11 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 2.502136e-11 |
GO:0003009 | skeletal muscle contraction | 5.775061e-11 |
GO:0006956 | complement activation | 1.972801e-10 |
GO:0043462 | regulation of ATPase activity | 3.197246e-10 |
GO:0031329 | regulation of cellular catabolic process | 4.464996e-10 |
GO:0030421 | defecation | 4.634803e-10 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 5.986171e-10 |
GO:0007265 | Ras protein signal transduction | 1.330897e-9 |
GO:0071732 | cellular response to nitric oxide | 1.459729e-9 |
GO:0006958 | complement activation, classical pathway | 1.830211e-9 |
GO:0018350 | protein esterification | 2.244952e-9 |
GO:0044258 | intestinal lipid catabolic process | 2.244952e-9 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 2.289011e-9 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 2.702376e-9 |
GO:0006955 | immune response | 9.462416e-9 |
GO:0030225 | macrophage differentiation | 1.668266e-8 |
GO:0046902 | regulation of mitochondrial membrane permeability | 1.718425e-8 |
GO:0035814 | negative regulation of renal sodium excretion | 1.806615e-8 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 2.173423e-8 |
GO:0034014 | response to triglyceride | 2.247967e-8 |
GO:0044062 | regulation of excretion | 3.179000e-8 |
GO:0033121 | regulation of purine nucleotide catabolic process | 3.417673e-8 |
GO:0008078 | mesodermal cell migration | 3.847474e-8 |
GO:0034505 | tooth mineralization | 4.012071e-8 |
GO:0019883 | antigen processing and presentation of endogenous antigen | 4.353436e-8 |
GO:0061099 | negative regulation of protein tyrosine kinase activity | 4.647156e-8 |
GO:0002906 | negative regulation of mature B cell apoptosis | 4.802152e-8 |
GO:0061014 | positive regulation of mRNA catabolic process | 5.565857e-8 |
GO:0003229 | ventricular cardiac muscle tissue development | 6.648303e-8 |
GO:0090209 | negative regulation of triglyceride metabolic process | 7.617067e-8 |
GO:0033189 | response to vitamin A | 7.866638e-8 |
GO:0051591 | response to cAMP | 1.101131e-7 |
GO:0007266 | Rho protein signal transduction | 1.256163e-7 |
GO:0009303 | rRNA transcription | 1.461427e-7 |
GO:0007512 | adult heart development | 1.522329e-7 |
GO:0048143 | astrocyte activation | 1.556378e-7 |
GO:0051044 | positive regulation of membrane protein ectodomain proteolysis | 1.666104e-7 |
GO:0046164 | alcohol catabolic process | 1.708621e-7 |
GO:0043587 | tongue morphogenesis | 2.019320e-7 |
GO:0048144 | fibroblast proliferation | 2.188174e-7 |
GO:0010829 | negative regulation of glucose transport | 2.224492e-7 |
GO:0014805 | smooth muscle adaptation | 2.375759e-7 |
GO:0034116 | positive regulation of heterotypic cell-cell adhesion | 2.468479e-7 |
GO:0006700 | C21-steroid hormone biosynthetic process | 3.058619e-7 |
GO:0071731 | response to nitric oxide | 3.211404e-7 |
GO:0031960 | response to corticosteroid stimulus | 3.342348e-7 |
GO:0015696 | ammonium transport | 3.538825e-7 |
GO:0032782 | bile acid secretion | 3.574742e-7 |
GO:0003012 | muscle system process | 3.609633e-7 |
GO:0030162 | regulation of proteolysis | 3.728637e-7 |
GO:0001666 | response to hypoxia | 3.860386e-7 |
GO:0010625 | positive regulation of Schwann cell proliferation | 4.637817e-7 |
GO:0050909 | sensory perception of taste | 4.751136e-7 |
GO:0046365 | monosaccharide catabolic process | 4.923021e-7 |
GO:0044057 | regulation of system process | 4.928245e-7 |
GO:0045059 | positive thymic T cell selection | 5.024948e-7 |
GO:0006935 | chemotaxis | 5.091386e-7 |
GO:0030157 | pancreatic juice secretion | 5.184435e-7 |
GO:0007522 | visceral muscle development | 5.222711e-7 |
GO:0019320 | hexose catabolic process | 5.955172e-7 |
GO:0016052 | carbohydrate catabolic process | 6.211921e-7 |
GO:0042137 | sequestering of neurotransmitter | 6.455572e-7 |
GO:0006140 | regulation of nucleotide metabolic process | 6.535524e-7 |
GO:0010987 | negative regulation of high-density lipoprotein particle clearance | 6.758419e-7 |
GO:0010897 | negative regulation of triglyceride catabolic process | 6.758419e-7 |
GO:0002528 | regulation of vascular permeability involved in acute inflammatory response | 7.204151e-7 |
GO:0016140 | O-glycoside metabolic process | 7.585580e-7 |
GO:0046521 | sphingoid catabolic process | 9.166668e-7 |
GO:0048167 | regulation of synaptic plasticity | 9.592183e-7 |
GO:0009052 | pentose-phosphate shunt, non-oxidative branch | 1.022042e-6 |
GO:0030730 | sequestering of triglyceride | 1.054304e-6 |
GO:0015760 | glucose-6-phosphate transport | 1.070200e-6 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 1.238052e-6 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 1.347732e-6 |
GO:0031440 | regulation of mRNA 3'-end processing | 1.436599e-6 |
GO:0022010 | central nervous system myelination | 1.464719e-6 |
GO:0042488 | positive regulation of odontogenesis of dentine-containing tooth | 1.481157e-6 |
GO:0060020 | Bergmann glial cell differentiation | 1.486858e-6 |
GO:0042851 | L-alanine metabolic process | 1.511628e-6 |
GO:0071474 | cellular hyperosmotic response | 1.541326e-6 |
GO:0060611 | mammary gland fat development | 1.609492e-6 |
GO:0048708 | astrocyte differentiation | 1.628046e-6 |
GO:0000302 | response to reactive oxygen species | 1.653472e-6 |
GO:0006707 | cholesterol catabolic process | 1.682078e-6 |
GO:0045109 | intermediate filament organization | 1.720046e-6 |
GO:0060444 | branching involved in mammary gland duct morphogenesis | 1.804162e-6 |
GO:0033273 | response to vitamin | 1.883538e-6 |
GO:2000272 | negative regulation of receptor activity | 1.940237e-6 |
GO:0009605 | response to external stimulus | 1.968914e-6 |
GO:0070482 | response to oxygen levels | 2.097592e-6 |
GO:0002026 | regulation of the force of heart contraction | 2.196698e-6 |
GO:0072333 | signal transduction by p53 class mediator resulting in induction of anoikis | 2.302333e-6 |
GO:0010985 | negative regulation of lipoprotein particle clearance | 2.368860e-6 |
GO:0015695 | organic cation transport | 2.469264e-6 |
GO:0032526 | response to retinoic acid | 2.756686e-6 |
GO:0042446 | hormone biosynthetic process | 2.854480e-6 |
GO:0010916 | negative regulation of very-low-density lipoprotein particle clearance | 2.884428e-6 |
GO:0042074 | cell migration involved in gastrulation | 3.076814e-6 |
GO:0033131 | regulation of glucokinase activity | 3.097920e-6 |
GO:0016142 | O-glycoside catabolic process | 3.173116e-6 |
GO:0072376 | protein activation cascade | 3.472275e-6 |
GO:0071529 | cementum mineralization | 3.553414e-6 |
GO:0010989 | negative regulation of low-density lipoprotein particle clearance | 3.602938e-6 |
GO:0071230 | cellular response to amino acid stimulus | 3.621285e-6 |
GO:0030198 | extracellular matrix organization | 3.737787e-6 |
GO:0030853 | negative regulation of granulocyte differentiation | 3.835119e-6 |
GO:0040019 | positive regulation of embryonic development | 3.891985e-6 |
GO:0014909 | smooth muscle cell migration | 3.909341e-6 |
GO:0031295 | T cell costimulation | 4.333281e-6 |
GO:0030835 | negative regulation of actin filament depolymerization | 4.386258e-6 |
GO:0051693 | actin filament capping | 4.705026e-6 |
GO:0014002 | astrocyte development | 4.980712e-6 |
GO:0071496 | cellular response to external stimulus | 5.052181e-6 |
GO:0035813 | regulation of renal sodium excretion | 5.318586e-6 |
GO:0019098 | reproductive behavior | 5.358390e-6 |
GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity | 5.399950e-6 |
GO:0044240 | multicellular organismal lipid catabolic process | 5.430745e-6 |
GO:0048545 | response to steroid hormone stimulus | 5.495457e-6 |
GO:0006620 | posttranslational protein targeting to membrane | 5.589814e-6 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 5.660522e-6 |
GO:0050896 | response to stimulus | 5.813966e-6 |
GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep | 6.159551e-6 |
GO:0000432 | positive regulation of transcription from RNA polymerase II promoter by glucose | 6.159551e-6 |
GO:2000251 | positive regulation of actin cytoskeleton reorganization | 6.175769e-6 |
GO:0042363 | fat-soluble vitamin catabolic process | 6.382708e-6 |
GO:0043206 | fibril organization | 6.848448e-6 |
GO:0050779 | RNA destabilization | 6.851081e-6 |
GO:0060346 | bone trabecula formation | 7.041308e-6 |
GO:0002019 | regulation of renal output by angiotensin | 7.057018e-6 |
GO:0001957 | intramembranous ossification | 7.065826e-6 |
GO:0002921 | negative regulation of humoral immune response | 7.096413e-6 |
GO:0009894 | regulation of catabolic process | 7.127225e-6 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 7.383778e-6 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 7.592262e-6 |
GO:0002923 | regulation of humoral immune response mediated by circulating immunoglobulin | 7.617407e-6 |
GO:0044275 | cellular carbohydrate catabolic process | 8.124525e-6 |
GO:0006936 | muscle contraction | 8.346421e-6 |
GO:0043586 | tongue development | 8.366154e-6 |
GO:0010896 | regulation of triglyceride catabolic process | 8.410495e-6 |
GO:0070208 | protein heterotrimerization | 9.006889e-6 |
GO:0006952 | defense response | 9.360878e-6 |
GO:0007509 | mesoderm migration involved in gastrulation | 9.439891e-6 |
GO:0016056 | rhodopsin mediated signaling pathway | 9.627863e-6 |
GO:0030643 | cellular phosphate ion homeostasis | 9.715241e-6 |
GO:0070625 | zymogen granule exocytosis | 1.003174e-5 |
GO:0032272 | negative regulation of protein polymerization | 1.027393e-5 |
GO:0043547 | positive regulation of GTPase activity | 1.118045e-5 |
GO:0051043 | regulation of membrane protein ectodomain proteolysis | 1.129060e-5 |
GO:0002920 | regulation of humoral immune response | 1.178499e-5 |
GO:0061143 | alveolar primary septum development | 1.188650e-5 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 1.188650e-5 |
GO:0044342 | type B pancreatic cell proliferation | 1.188650e-5 |
GO:0015758 | glucose transport | 1.193641e-5 |
GO:0033693 | neurofilament bundle assembly | 1.209575e-5 |
GO:0033057 | multicellular organismal reproductive behavior | 1.354278e-5 |
GO:0032312 | regulation of ARF GTPase activity | 1.361055e-5 |
GO:0035176 | social behavior | 1.430452e-5 |
GO:0007096 | regulation of exit from mitosis | 1.470366e-5 |
GO:0051494 | negative regulation of cytoskeleton organization | 1.483274e-5 |
GO:0048659 | smooth muscle cell proliferation | 1.484634e-5 |
GO:0072109 | glomerular mesangium development | 1.498762e-5 |
GO:0040040 | thermosensory behavior | 1.573504e-5 |
GO:0031915 | positive regulation of synaptic plasticity | 1.590557e-5 |
GO:0072110 | glomerular mesangial cell proliferation | 1.693192e-5 |
GO:0006021 | inositol biosynthetic process | 1.731479e-5 |
GO:0030316 | osteoclast differentiation | 1.757743e-5 |
GO:0015891 | siderophore transport | 1.908810e-5 |
GO:0001705 | ectoderm formation | 1.908810e-5 |
GO:0007621 | negative regulation of female receptivity | 1.943665e-5 |
GO:0006897 | endocytosis | 2.006242e-5 |
GO:0060158 | activation of phospholipase C activity by dopamine receptor signaling pathway | 2.054007e-5 |
GO:0046514 | ceramide catabolic process | 2.083646e-5 |
GO:0048627 | myoblast development | 2.121917e-5 |
GO:0008645 | hexose transport | 2.149696e-5 |
GO:0016264 | gap junction assembly | 2.164600e-5 |
GO:0032964 | collagen biosynthetic process | 2.196985e-5 |
GO:0006959 | humoral immune response | 2.231505e-5 |
GO:0071418 | cellular response to amine stimulus | 2.292784e-5 |
GO:0016064 | immunoglobulin mediated immune response | 2.310976e-5 |
GO:0046103 | inosine biosynthetic process | 2.348902e-5 |
GO:0045575 | basophil activation | 2.348902e-5 |
GO:0001694 | histamine biosynthetic process | 2.348902e-5 |
GO:0006154 | adenosine catabolic process | 2.348902e-5 |
GO:0042982 | amyloid precursor protein metabolic process | 2.379508e-5 |
GO:0043589 | skin morphogenesis | 2.380373e-5 |
GO:0008211 | glucocorticoid metabolic process | 2.392755e-5 |
GO:0019087 | transformation of host cell by virus | 2.482614e-5 |
GO:0030952 | establishment or maintenance of cytoskeleton polarity | 2.546045e-5 |
GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process | 2.613669e-5 |
GO:0045924 | regulation of female receptivity | 2.645274e-5 |
GO:0034097 | response to cytokine stimulus | 2.678852e-5 |
GO:0001956 | positive regulation of neurotransmitter secretion | 2.808967e-5 |
GO:0035105 | sterol regulatory element binding protein import into nucleus | 2.834782e-5 |
GO:0015749 | monosaccharide transport | 2.863202e-5 |
GO:0051588 | regulation of neurotransmitter transport | 2.892739e-5 |
GO:0060559 | positive regulation of calcidiol 1-monooxygenase activity | 2.950556e-5 |
GO:0045014 | negative regulation of transcription by glucose | 2.952820e-5 |
GO:0071417 | cellular response to organic nitrogen | 2.960338e-5 |
GO:0034635 | glutathione transport | 3.027766e-5 |
GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 3.431267e-5 |
GO:0009304 | tRNA transcription | 3.431267e-5 |
GO:0006012 | galactose metabolic process | 3.480898e-5 |
GO:0048243 | norepinephrine secretion | 3.515482e-5 |
GO:0060343 | trabecula formation | 3.657957e-5 |
GO:0046015 | regulation of transcription by glucose | 3.661336e-5 |
GO:0032796 | uropod organization | 3.661336e-5 |
GO:0060033 | anatomical structure regression | 3.728464e-5 |
GO:0010959 | regulation of metal ion transport | 3.757717e-5 |
GO:0003184 | pulmonary valve morphogenesis | 3.778924e-5 |
GO:0031424 | keratinization | 3.888945e-5 |
GO:0010994 | free ubiquitin chain polymerization | 4.038180e-5 |
GO:0042797 | tRNA transcription from RNA polymerase III promoter | 4.101651e-5 |
GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter | 4.101651e-5 |
GO:0031508 | centromeric heterochromatin formation | 4.102648e-5 |
GO:0071702 | organic substance transport | 4.181611e-5 |
GO:0007617 | mating behavior | 4.184005e-5 |
GO:2000001 | regulation of DNA damage checkpoint | 4.190305e-5 |
GO:0043087 | regulation of GTPase activity | 4.203061e-5 |
GO:0030837 | negative regulation of actin filament polymerization | 4.266913e-5 |
GO:0033209 | tumor necrosis factor-mediated signaling pathway | 4.434326e-5 |
GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process | 4.583259e-5 |
GO:0010988 | regulation of low-density lipoprotein particle clearance | 4.677762e-5 |
GO:0045581 | negative regulation of T cell differentiation | 4.808979e-5 |
GO:0002573 | myeloid leukocyte differentiation | 5.054518e-5 |
GO:0001973 | adenosine receptor signaling pathway | 5.136198e-5 |
GO:0045862 | positive regulation of proteolysis | 5.189082e-5 |
GO:0072111 | cell proliferation involved in kidney development | 5.250091e-5 |
GO:0006007 | glucose catabolic process | 5.305722e-5 |
GO:0006066 | alcohol metabolic process | 5.306231e-5 |
GO:0033132 | negative regulation of glucokinase activity | 5.637942e-5 |
GO:0019048 | virus-host interaction | 5.644458e-5 |
GO:0048873 | homeostasis of number of cells within a tissue | 5.718478e-5 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 5.753440e-5 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 5.865810e-5 |
GO:0042761 | very long-chain fatty acid biosynthetic process | 6.049003e-5 |
GO:0019221 | cytokine-mediated signaling pathway | 6.238469e-5 |
GO:0032957 | inositol trisphosphate metabolic process | 6.269645e-5 |
GO:0051533 | positive regulation of NFAT protein import into nucleus | 6.329945e-5 |
GO:0007021 | tubulin complex assembly | 6.428759e-5 |
GO:0051293 | establishment of spindle localization | 6.529376e-5 |
GO:0035249 | synaptic transmission, glutamatergic | 7.065729e-5 |
GO:0010193 | response to ozone | 7.129442e-5 |
GO:0045061 | thymic T cell selection | 7.153912e-5 |
GO:0006701 | progesterone biosynthetic process | 7.222267e-5 |
GO:0010624 | regulation of Schwann cell proliferation | 7.230513e-5 |
GO:0023019 | signal transduction involved in regulation of gene expression | 7.358609e-5 |
GO:0007296 | vitellogenesis | 7.780256e-5 |
GO:0031670 | cellular response to nutrient | 7.838438e-5 |
GO:0043163 | cell envelope organization | 8.171052e-5 |
GO:0050995 | negative regulation of lipid catabolic process | 8.295132e-5 |
GO:0060763 | mammary duct terminal end bud growth | 8.486414e-5 |
GO:0060712 | spongiotrophoblast layer development | 8.606790e-5 |
GO:0050881 | musculoskeletal movement | 8.958138e-5 |
GO:0061048 | negative regulation of branching involved in lung morphogenesis | 8.966236e-5 |
GO:0007165 | signal transduction | 9.135153e-5 |
GO:0070256 | negative regulation of mucus secretion | 9.228256e-5 |
GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep | 9.228256e-5 |
GO:0002903 | negative regulation of B cell apoptosis | 9.257646e-5 |
GO:0002502 | peptide antigen assembly with MHC class I protein complex | 9.289045e-5 |
GO:2000210 | positive regulation of anoikis | 9.299552e-5 |
GO:0070164 | negative regulation of adiponectin secretion | 9.381740e-5 |
GO:0035505 | positive regulation of myosin light chain kinase activity | 9.381740e-5 |
GO:0060355 | positive regulation of cell adhesion molecule production | 9.381740e-5 |
GO:0061383 | trabecula morphogenesis | 9.594375e-5 |
GO:0034612 | response to tumor necrosis factor | 9.886747e-5 |
GO:0007154 | cell communication | 9.944674e-5 |
GO:0042542 | response to hydrogen peroxide | 1.046182e-4 |
GO:0007274 | neuromuscular synaptic transmission | 1.058169e-4 |
GO:0071460 | cellular response to cell-matrix adhesion | 1.071293e-4 |
GO:0007271 | synaptic transmission, cholinergic | 1.087694e-4 |
GO:0051927 | negative regulation of calcium ion transport via voltage-gated calcium channel activity | 1.090815e-4 |
GO:0042117 | monocyte activation | 1.120310e-4 |
GO:0009416 | response to light stimulus | 1.124910e-4 |
GO:0042987 | amyloid precursor protein catabolic process | 1.129397e-4 |
GO:0008015 | blood circulation | 1.148092e-4 |
GO:0034340 | response to type I interferon | 1.151171e-4 |
GO:0009651 | response to salt stress | 1.183053e-4 |
GO:0061180 | mammary gland epithelium development | 1.208250e-4 |
GO:0033124 | regulation of GTP catabolic process | 1.261550e-4 |
GO:2000543 | positive regulation of gastrulation | 1.268361e-4 |
GO:0010872 | regulation of cholesterol esterification | 1.277583e-4 |
GO:0009992 | cellular water homeostasis | 1.280875e-4 |
GO:0032233 | positive regulation of actin filament bundle assembly | 1.290234e-4 |
GO:0070593 | dendrite self-avoidance | 1.307468e-4 |
GO:0045604 | regulation of epidermal cell differentiation | 1.347544e-4 |
GO:0042445 | hormone metabolic process | 1.410629e-4 |
GO:0008217 | regulation of blood pressure | 1.440078e-4 |
GO:0051384 | response to glucocorticoid stimulus | 1.448735e-4 |
GO:0016032 | viral reproduction | 1.507964e-4 |
GO:0055062 | phosphate ion homeostasis | 1.533280e-4 |
GO:0071260 | cellular response to mechanical stimulus | 1.548112e-4 |
GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus | 1.575045e-4 |
GO:0071276 | cellular response to cadmium ion | 1.609545e-4 |
GO:0006026 | aminoglycan catabolic process | 1.615901e-4 |
GO:0051924 | regulation of calcium ion transport | 1.616921e-4 |
GO:0014873 | response to muscle activity involved in regulation of muscle adaptation | 1.625901e-4 |
GO:0061049 | cell growth involved in cardiac muscle cell development | 1.625901e-4 |
GO:0003331 | positive regulation of extracellular matrix constituent secretion | 1.625901e-4 |
GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure | 1.625901e-4 |
GO:0030834 | regulation of actin filament depolymerization | 1.709879e-4 |
GO:0042108 | positive regulation of cytokine biosynthetic process | 1.716539e-4 |
GO:0033326 | cerebrospinal fluid secretion | 1.721499e-4 |
GO:0043094 | cellular metabolic compound salvage | 1.753439e-4 |
GO:0070163 | regulation of adiponectin secretion | 1.778999e-4 |
GO:2000976 | regulation of transcription from RNA polymerase II promoter involved in detection of glucose | 1.783415e-4 |
GO:2000971 | negative regulation of detection of glucose | 1.783415e-4 |
GO:0000433 | negative regulation of transcription from RNA polymerase II promoter by glucose | 1.783415e-4 |
GO:0061013 | regulation of mRNA catabolic process | 1.850697e-4 |
GO:0060337 | type I interferon-mediated signaling pathway | 1.850947e-4 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 1.854276e-4 |
GO:0010544 | negative regulation of platelet activation | 1.855377e-4 |
GO:2000209 | regulation of anoikis | 1.875174e-4 |
GO:0032218 | riboflavin transport | 1.890554e-4 |
GO:0016188 | synaptic vesicle maturation | 1.926606e-4 |
GO:0046827 | positive regulation of protein export from nucleus | 1.941014e-4 |
GO:0009612 | response to mechanical stimulus | 1.945427e-4 |
GO:0060035 | notochord cell development | 1.947947e-4 |
GO:0008292 | acetylcholine biosynthetic process | 1.947947e-4 |
GO:0071299 | cellular response to vitamin A | 1.974561e-4 |
GO:0044281 | small molecule metabolic process | 2.047163e-4 |
GO:0035556 | intracellular signal transduction | 2.063863e-4 |
GO:0050435 | beta-amyloid metabolic process | 2.080320e-4 |
GO:0019724 | B cell mediated immunity | 2.097374e-4 |
GO:0046333 | octopamine metabolic process | 2.104805e-4 |
GO:0042309 | homoiothermy | 2.104805e-4 |
GO:0009235 | cobalamin metabolic process | 2.111919e-4 |
GO:0031914 | negative regulation of synaptic plasticity | 2.111919e-4 |
GO:0006032 | chitin catabolic process | 2.156212e-4 |
GO:0033559 | unsaturated fatty acid metabolic process | 2.165535e-4 |
GO:0006954 | inflammatory response | 2.206126e-4 |
GO:0003417 | growth plate cartilage development | 2.207543e-4 |
GO:0002685 | regulation of leukocyte migration | 2.208121e-4 |
GO:0060669 | embryonic placenta morphogenesis | 2.254956e-4 |
GO:0032289 | central nervous system myelin formation | 2.272365e-4 |
GO:0045760 | positive regulation of action potential | 2.290217e-4 |
GO:0032846 | positive regulation of homeostatic process | 2.319282e-4 |
GO:0046102 | inosine metabolic process | 2.350567e-4 |
GO:0017085 | response to insecticide | 2.406709e-4 |
GO:0060789 | hair follicle placode formation | 2.500219e-4 |
GO:0010868 | negative regulation of triglyceride biosynthetic process | 2.513488e-4 |
GO:0006663 | platelet activating factor biosynthetic process | 2.513488e-4 |
GO:0046627 | negative regulation of insulin receptor signaling pathway | 2.572571e-4 |
GO:0042345 | regulation of NF-kappaB import into nucleus | 2.649316e-4 |
GO:0009650 | UV protection | 2.775154e-4 |
GO:0048675 | axon extension | 2.911195e-4 |
GO:0006704 | glucocorticoid biosynthetic process | 2.930354e-4 |
GO:0055093 | response to hyperoxia | 2.938879e-4 |
GO:0045657 | positive regulation of monocyte differentiation | 2.979187e-4 |
GO:0010984 | regulation of lipoprotein particle clearance | 2.979187e-4 |
GO:0061205 | paramesonephric duct development | 2.983137e-4 |
GO:0032370 | positive regulation of lipid transport | 3.059727e-4 |
GO:0044243 | multicellular organismal catabolic process | 3.067140e-4 |
GO:0045060 | negative thymic T cell selection | 3.072238e-4 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 3.108356e-4 |
GO:0071506 | cellular response to mycophenolic acid | 3.108356e-4 |
GO:0014057 | positive regulation of acetylcholine secretion | 3.144598e-4 |
GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 3.186840e-4 |
GO:0051590 | positive regulation of neurotransmitter transport | 3.223882e-4 |
GO:0007398 | ectoderm development | 3.335079e-4 |
GO:0008624 | induction of apoptosis by extracellular signals | 3.354814e-4 |
GO:0046469 | platelet activating factor metabolic process | 3.371391e-4 |
GO:0042401 | cellular biogenic amine biosynthetic process | 3.372038e-4 |
GO:0002443 | leukocyte mediated immunity | 3.472590e-4 |
GO:0060456 | positive regulation of digestive system process | 3.476309e-4 |
GO:0030187 | melatonin biosynthetic process | 3.505979e-4 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 3.569739e-4 |
GO:0051336 | regulation of hydrolase activity | 3.606268e-4 |
GO:0070327 | thyroid hormone transport | 3.612699e-4 |
GO:0042487 | regulation of odontogenesis of dentine-containing tooth | 3.650794e-4 |
GO:0001692 | histamine metabolic process | 3.686276e-4 |
GO:0090207 | regulation of triglyceride metabolic process | 3.775014e-4 |
GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway | 3.794116e-4 |
GO:0048588 | developmental cell growth | 3.828420e-4 |
GO:0006020 | inositol metabolic process | 3.832394e-4 |
GO:0045620 | negative regulation of lymphocyte differentiation | 3.836804e-4 |
GO:0070914 | UV-damage excision repair | 3.840330e-4 |
GO:0009258 | 10-formyltetrahydrofolate catabolic process | 3.840330e-4 |
GO:0061370 | testosterone biosynthetic process | 3.840330e-4 |
GO:0033595 | response to genistein | 3.840330e-4 |
GO:0050756 | fractalkine metabolic process | 3.840330e-4 |
GO:0018208 | peptidyl-proline modification | 3.856637e-4 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 3.887423e-4 |
GO:0007174 | epidermal growth factor catabolic process | 3.887423e-4 |
GO:0045655 | regulation of monocyte differentiation | 3.915021e-4 |
GO:0048146 | positive regulation of fibroblast proliferation | 3.983966e-4 |
GO:0019896 | axon transport of mitochondrion | 3.984632e-4 |
GO:0071300 | cellular response to retinoic acid | 3.991704e-4 |
GO:0042512 | negative regulation of tyrosine phosphorylation of Stat1 protein | 4.000201e-4 |
GO:0006196 | AMP catabolic process | 4.000201e-4 |
GO:0019388 | galactose catabolic process | 4.000201e-4 |
GO:0060154 | cellular process regulating host cell cycle in response to virus | 4.057075e-4 |
GO:0002830 | positive regulation of type 2 immune response | 4.101669e-4 |
GO:0019318 | hexose metabolic process | 4.160492e-4 |
GO:0046325 | negative regulation of glucose import | 4.165329e-4 |
GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin | 4.198045e-4 |
GO:0046928 | regulation of neurotransmitter secretion | 4.217147e-4 |
GO:0043500 | muscle adaptation | 4.217147e-4 |
GO:0007006 | mitochondrial membrane organization | 4.268993e-4 |
GO:0045047 | protein targeting to ER | 4.406356e-4 |
GO:0072060 | outer medullary collecting duct development | 4.421726e-4 |
GO:0072061 | inner medullary collecting duct development | 4.421726e-4 |
GO:0006552 | leucine catabolic process | 4.421726e-4 |
GO:0016332 | establishment or maintenance of polarity of embryonic epithelium | 4.421726e-4 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 4.480177e-4 |
GO:0043244 | regulation of protein complex disassembly | 4.594278e-4 |
GO:0035377 | transepithelial water transport | 4.619396e-4 |
GO:0085018 | maintenance of symbiont-containing vacuole via substance secreted by host | 4.619396e-4 |
GO:0035378 | carbon dioxide transmembrane transport | 4.619396e-4 |
GO:0032972 | regulation of muscle filament sliding speed | 4.619396e-4 |
GO:0030950 | establishment or maintenance of actin cytoskeleton polarity | 4.619396e-4 |
GO:0019402 | galactitol metabolic process | 4.690991e-4 |
GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus | 4.690991e-4 |
GO:0045112 | integrin biosynthetic process | 4.735706e-4 |
GO:0002313 | mature B cell differentiation involved in immune response | 4.805117e-4 |
GO:0045110 | intermediate filament bundle assembly | 4.806511e-4 |
GO:0001808 | negative regulation of type IV hypersensitivity | 4.825286e-4 |
GO:0033013 | tetrapyrrole metabolic process | 4.870423e-4 |
GO:0015670 | carbon dioxide transport | 4.877065e-4 |
GO:0002579 | positive regulation of antigen processing and presentation | 4.907341e-4 |
GO:0051705 | behavioral interaction between organisms | 4.920458e-4 |
GO:0009628 | response to abiotic stimulus | 4.980161e-4 |
GO:0007163 | establishment or maintenance of cell polarity | 5.040300e-4 |
GO:0060708 | spongiotrophoblast differentiation | 5.121049e-4 |
GO:0043266 | regulation of potassium ion transport | 5.151877e-4 |
GO:0032725 | positive regulation of granulocyte macrophage colony-stimulating factor production | 5.196965e-4 |
GO:0046456 | icosanoid biosynthetic process | 5.381369e-4 |
GO:0002070 | epithelial cell maturation | 5.412303e-4 |
GO:0072177 | mesonephric duct development | 5.583234e-4 |
GO:0090002 | establishment of protein localization in plasma membrane | 5.597685e-4 |
GO:0071280 | cellular response to copper ion | 5.666044e-4 |
GO:0014028 | notochord formation | 5.666044e-4 |
GO:0010536 | positive regulation of activation of Janus kinase activity | 5.748633e-4 |
GO:0031652 | positive regulation of heat generation | 5.888141e-4 |
GO:0045920 | negative regulation of exocytosis | 5.936848e-4 |
GO:0045820 | negative regulation of glycolysis | 6.044818e-4 |
GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway | 6.282543e-4 |
GO:0043103 | hypoxanthine salvage | 6.341119e-4 |
GO:0007264 | small GTPase mediated signal transduction | 6.413777e-4 |
GO:0090150 | establishment of protein localization in membrane | 6.433381e-4 |
GO:0046473 | phosphatidic acid metabolic process | 6.433381e-4 |
GO:0001516 | prostaglandin biosynthetic process | 6.462844e-4 |
GO:0018916 | nitrobenzene metabolic process | 6.486510e-4 |
GO:0001867 | complement activation, lectin pathway | 6.660352e-4 |
GO:0048488 | synaptic vesicle endocytosis | 6.784311e-4 |
GO:0023052 | signaling | 6.941282e-4 |
GO:0070309 | lens fiber cell morphogenesis | 6.945937e-4 |
GO:0031536 | positive regulation of exit from mitosis | 7.120086e-4 |
GO:0008643 | carbohydrate transport | 7.172916e-4 |
GO:0002449 | lymphocyte mediated immunity | 7.205154e-4 |
GO:0071214 | cellular response to abiotic stimulus | 7.245576e-4 |
GO:0002252 | immune effector process | 7.274003e-4 |
GO:0019376 | galactolipid catabolic process | 7.394175e-4 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 7.448370e-4 |
GO:0070972 | protein localization in endoplasmic reticulum | 7.467485e-4 |
GO:0046466 | membrane lipid catabolic process | 7.541649e-4 |
GO:0051205 | protein insertion into membrane | 7.642825e-4 |
GO:0010216 | maintenance of DNA methylation | 7.643014e-4 |
GO:0051005 | negative regulation of lipoprotein lipase activity | 7.685299e-4 |
GO:0003300 | cardiac muscle hypertrophy | 7.862567e-4 |
GO:0060252 | positive regulation of glial cell proliferation | 7.872234e-4 |
GO:0019693 | ribose phosphate metabolic process | 7.968320e-4 |
GO:0003416 | endochondral bone growth | 7.968320e-4 |
GO:0000132 | establishment of mitotic spindle orientation | 7.998669e-4 |
GO:0043647 | inositol phosphate metabolic process | 8.035629e-4 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 8.035629e-4 |
GO:0070228 | regulation of lymphocyte apoptosis | 8.113947e-4 |
GO:0032729 | positive regulation of interferon-gamma production | 8.156767e-4 |
GO:0050690 | regulation of defense response to virus by virus | 8.221399e-4 |
GO:0007212 | dopamine receptor signaling pathway | 8.539616e-4 |
GO:0071593 | lymphocyte aggregation | 8.622167e-4 |
GO:0090205 | positive regulation of cholesterol metabolic process | 8.641773e-4 |
GO:0045682 | regulation of epidermis development | 9.089775e-4 |
GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway | 9.181448e-4 |
GO:0051881 | regulation of mitochondrial membrane potential | 9.230252e-4 |
GO:0071356 | cellular response to tumor necrosis factor | 9.551563e-4 |
GO:0021700 | developmental maturation | 9.627890e-4 |
GO:0072661 | protein targeting to plasma membrane | 9.681246e-4 |
GO:0033002 | muscle cell proliferation | 9.722342e-4 |
GO:0051764 | actin crosslink formation | 9.761695e-4 |
GO:0071229 | cellular response to acid | 9.809305e-4 |
GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus | 9.931879e-4 |
GO:0044140 | negative regulation of growth of symbiont on or near host surface | 1.002044e-3 |
GO:0006258 | UDP-glucose catabolic process | 1.002044e-3 |
GO:0032231 | regulation of actin filament bundle assembly | 1.015081e-3 |
GO:0002086 | diaphragm contraction | 1.026197e-3 |
GO:0015868 | purine ribonucleotide transport | 1.028699e-3 |
GO:0019511 | peptidyl-proline hydroxylation | 1.030648e-3 |
GO:0002902 | regulation of B cell apoptosis | 1.030669e-3 |
GO:0002828 | regulation of type 2 immune response | 1.040841e-3 |
GO:0060560 | developmental growth involved in morphogenesis | 1.042994e-3 |
GO:0010243 | response to organic nitrogen | 1.054040e-3 |
GO:0007584 | response to nutrient | 1.056986e-3 |
GO:0032355 | response to estradiol stimulus | 1.079005e-3 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0071496 | cellular response to external stimulus | 3.696288e-12 |
GO:0009725 | response to hormone stimulus | 3.568283e-11 |
GO:0046889 | positive regulation of lipid biosynthetic process | 1.592805e-10 |
GO:0006982 | response to lipid hydroperoxide | 9.972743e-10 |
GO:0009611 | response to wounding | 2.562466e-9 |
GO:0010033 | response to organic substance | 2.804958e-9 |
GO:0009719 | response to endogenous stimulus | 3.440995e-9 |
GO:0007586 | digestion | 3.563587e-9 |
GO:0044240 | multicellular organismal lipid catabolic process | 4.268195e-9 |
GO:0042760 | very long-chain fatty acid catabolic process | 5.405643e-9 |
GO:0034505 | tooth mineralization | 6.464628e-9 |
GO:0001957 | intramembranous ossification | 6.730883e-9 |
GO:0034097 | response to cytokine stimulus | 7.374844e-9 |
GO:0044243 | multicellular organismal catabolic process | 1.254955e-8 |
GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling | 1.279527e-8 |
GO:0031668 | cellular response to extracellular stimulus | 1.428583e-8 |
GO:0045940 | positive regulation of steroid metabolic process | 1.610832e-8 |
GO:0060346 | bone trabecula formation | 1.700029e-8 |
GO:0031960 | response to corticosteroid stimulus | 2.317549e-8 |
GO:0044241 | lipid digestion | 2.369759e-8 |
GO:0048545 | response to steroid hormone stimulus | 2.552752e-8 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 2.623704e-8 |
GO:0061077 | chaperone-mediated protein folding | 2.736317e-8 |
GO:0045723 | positive regulation of fatty acid biosynthetic process | 4.414075e-8 |
GO:0071260 | cellular response to mechanical stimulus | 5.275455e-8 |
GO:0044236 | multicellular organismal metabolic process | 5.293844e-8 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 1.012005e-7 |
GO:0009636 | response to toxin | 2.150855e-7 |
GO:0010893 | positive regulation of steroid biosynthetic process | 2.530505e-7 |
GO:0090023 | positive regulation of neutrophil chemotaxis | 2.856139e-7 |
GO:0032964 | collagen biosynthetic process | 3.122691e-7 |
GO:0006000 | fructose metabolic process | 3.392811e-7 |
GO:0008645 | hexose transport | 3.547009e-7 |
GO:0070208 | protein heterotrimerization | 4.648054e-7 |
GO:0071495 | cellular response to endogenous stimulus | 5.436157e-7 |
GO:0090031 | positive regulation of steroid hormone biosynthetic process | 6.277982e-7 |
GO:0000302 | response to reactive oxygen species | 6.358717e-7 |
GO:0009991 | response to extracellular stimulus | 6.467092e-7 |
GO:0002227 | innate immune response in mucosa | 6.695157e-7 |
GO:0042482 | positive regulation of odontogenesis | 7.538329e-7 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 8.755513e-7 |
GO:0051234 | establishment of localization | 9.062627e-7 |
GO:0043589 | skin morphogenesis | 1.009734e-6 |
GO:0015749 | monosaccharide transport | 1.038600e-6 |
GO:0071417 | cellular response to organic nitrogen | 1.074269e-6 |
GO:0071731 | response to nitric oxide | 1.097493e-6 |
GO:0002688 | regulation of leukocyte chemotaxis | 1.169699e-6 |
GO:0006954 | inflammatory response | 1.206767e-6 |
GO:0090022 | regulation of neutrophil chemotaxis | 1.318613e-6 |
GO:0031667 | response to nutrient levels | 1.419206e-6 |
GO:0031669 | cellular response to nutrient levels | 1.466736e-6 |
GO:0071418 | cellular response to amine stimulus | 1.510338e-6 |
GO:0032870 | cellular response to hormone stimulus | 1.530144e-6 |
GO:0007522 | visceral muscle development | 1.764109e-6 |
GO:0035094 | response to nicotine | 1.931803e-6 |
GO:0015758 | glucose transport | 1.934544e-6 |
GO:0051006 | positive regulation of lipoprotein lipase activity | 2.303862e-6 |
GO:0045792 | negative regulation of cell size | 2.701782e-6 |
GO:0071310 | cellular response to organic substance | 3.120562e-6 |
GO:0052548 | regulation of endopeptidase activity | 3.515968e-6 |
GO:0052547 | regulation of peptidase activity | 3.523711e-6 |
GO:0032963 | collagen metabolic process | 4.590605e-6 |
GO:0006952 | defense response | 4.612935e-6 |
GO:0060052 | neurofilament cytoskeleton organization | 4.754390e-6 |
GO:0043279 | response to alkaloid | 5.151843e-6 |
GO:0043313 | regulation of neutrophil degranulation | 5.299112e-6 |
GO:0006066 | alcohol metabolic process | 5.411776e-6 |
GO:0005996 | monosaccharide metabolic process | 5.421242e-6 |
GO:0042488 | positive regulation of odontogenesis of dentine-containing tooth | 6.108792e-6 |
GO:0022038 | corpus callosum development | 6.943473e-6 |
GO:0071230 | cellular response to amino acid stimulus | 7.014616e-6 |
GO:0006810 | transport | 7.142413e-6 |
GO:0010524 | positive regulation of calcium ion transport into cytosol | 7.463023e-6 |
GO:0070887 | cellular response to chemical stimulus | 8.285048e-6 |
GO:0014075 | response to amine stimulus | 8.762226e-6 |
GO:0043314 | negative regulation of neutrophil degranulation | 9.014450e-6 |
GO:0010898 | positive regulation of triglyceride catabolic process | 9.160360e-6 |
GO:0002690 | positive regulation of leukocyte chemotaxis | 9.302663e-6 |
GO:0071702 | organic substance transport | 9.588568e-6 |
GO:0043154 | negative regulation of caspase activity | 1.036440e-5 |
GO:0034445 | negative regulation of plasma lipoprotein particle oxidation | 1.093089e-5 |
GO:0051384 | response to glucocorticoid stimulus | 1.195748e-5 |
GO:0050432 | catecholamine secretion | 1.226987e-5 |
GO:0010466 | negative regulation of peptidase activity | 1.267445e-5 |
GO:0006547 | histidine metabolic process | 1.272759e-5 |
GO:0042743 | hydrogen peroxide metabolic process | 1.351642e-5 |
GO:0061032 | visceral serous pericardium development | 1.359540e-5 |
GO:0007620 | copulation | 1.370282e-5 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 1.454096e-5 |
GO:0090030 | regulation of steroid hormone biosynthetic process | 1.491495e-5 |
GO:0006006 | glucose metabolic process | 1.679825e-5 |
GO:0055090 | acylglycerol homeostasis | 1.720188e-5 |
GO:0043654 | recognition of apoptotic cell | 1.720188e-5 |
GO:0010522 | regulation of calcium ion transport into cytosol | 1.771734e-5 |
GO:0000105 | histidine biosynthetic process | 2.069611e-5 |
GO:0043462 | regulation of ATPase activity | 2.133422e-5 |
GO:2000116 | regulation of cysteine-type endopeptidase activity | 2.153704e-5 |
GO:0019853 | L-ascorbic acid biosynthetic process | 2.204840e-5 |
GO:0071214 | cellular response to abiotic stimulus | 2.229241e-5 |
GO:0032352 | positive regulation of hormone metabolic process | 2.252640e-5 |
GO:0002036 | regulation of L-glutamate transport | 2.625251e-5 |
GO:0006548 | histidine catabolic process | 2.798324e-5 |
GO:0042221 | response to chemical stimulus | 3.211657e-5 |
GO:0044281 | small molecule metabolic process | 3.322433e-5 |
GO:0030049 | muscle filament sliding | 3.393958e-5 |
GO:0001101 | response to acid | 3.394417e-5 |
GO:0043434 | response to peptide hormone stimulus | 3.404391e-5 |
GO:0071229 | cellular response to acid | 3.675127e-5 |
GO:0051238 | sequestering of metal ion | 3.778067e-5 |
GO:0007618 | mating | 3.976682e-5 |
GO:0021819 | layer formation in cerebral cortex | 4.098702e-5 |
GO:0034442 | regulation of lipoprotein oxidation | 4.257899e-5 |
GO:0010243 | response to organic nitrogen | 4.392890e-5 |
GO:0010312 | detoxification of zinc ion | 4.490372e-5 |
GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade | 4.566086e-5 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 4.577627e-5 |
GO:0032846 | positive regulation of homeostatic process | 4.725752e-5 |
GO:0006643 | membrane lipid metabolic process | 4.789843e-5 |
GO:0019318 | hexose metabolic process | 5.077893e-5 |
GO:0030388 | fructose 1,6-bisphosphate metabolic process | 5.228046e-5 |
GO:0071622 | regulation of granulocyte chemotaxis | 5.263751e-5 |
GO:0006766 | vitamin metabolic process | 5.347540e-5 |
GO:0070837 | dehydroascorbic acid transport | 6.127627e-5 |
GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 6.373120e-5 |
GO:0031295 | T cell costimulation | 6.628227e-5 |
GO:0046886 | positive regulation of hormone biosynthetic process | 6.853665e-5 |
GO:0060359 | response to ammonium ion | 6.957770e-5 |
GO:0060539 | diaphragm development | 7.397896e-5 |
GO:0071345 | cellular response to cytokine stimulus | 7.698020e-5 |
GO:0060299 | negative regulation of sarcomere organization | 7.984800e-5 |
GO:0044140 | negative regulation of growth of symbiont on or near host surface | 7.984800e-5 |
GO:0060307 | regulation of ventricular cardiomyocyte membrane repolarization | 7.984800e-5 |
GO:0032782 | bile acid secretion | 7.984800e-5 |
GO:0003096 | renal sodium ion transport | 7.984800e-5 |
GO:0006950 | response to stress | 8.035248e-5 |
GO:0034372 | very-low-density lipoprotein particle remodeling | 8.103426e-5 |
GO:0050748 | negative regulation of lipoprotein metabolic process | 8.541965e-5 |
GO:0009308 | amine metabolic process | 8.781058e-5 |
GO:0001675 | acrosome assembly | 8.881174e-5 |
GO:0048739 | cardiac muscle fiber development | 8.929679e-5 |
GO:0061098 | positive regulation of protein tyrosine kinase activity | 9.046553e-5 |
GO:0046885 | regulation of hormone biosynthetic process | 9.102271e-5 |
GO:0042364 | water-soluble vitamin biosynthetic process | 9.366285e-5 |
GO:0006044 | N-acetylglucosamine metabolic process | 9.555822e-5 |
GO:0000038 | very long-chain fatty acid metabolic process | 9.945849e-5 |
GO:0033233 | regulation of protein sumoylation | 1.012675e-4 |
GO:0043200 | response to amino acid stimulus | 1.027067e-4 |
GO:0048730 | epidermis morphogenesis | 1.043959e-4 |
GO:0032119 | sequestering of zinc ion | 1.091715e-4 |
GO:0042481 | regulation of odontogenesis | 1.112213e-4 |
GO:0016236 | macroautophagy | 1.136607e-4 |
GO:0051125 | regulation of actin nucleation | 1.147336e-4 |
GO:0009267 | cellular response to starvation | 1.160473e-4 |
GO:0045104 | intermediate filament cytoskeleton organization | 1.237138e-4 |
GO:0050729 | positive regulation of inflammatory response | 1.264147e-4 |
GO:0043624 | cellular protein complex disassembly | 1.290154e-4 |
GO:0070244 | negative regulation of thymocyte apoptosis | 1.335475e-4 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 1.367155e-4 |
GO:0007274 | neuromuscular synaptic transmission | 1.369712e-4 |
GO:0051788 | response to misfolded protein | 1.483710e-4 |
GO:0030212 | hyaluronan metabolic process | 1.593506e-4 |
GO:0043241 | protein complex disassembly | 1.631759e-4 |
GO:0046890 | regulation of lipid biosynthetic process | 1.632243e-4 |
GO:0051346 | negative regulation of hydrolase activity | 1.667800e-4 |
GO:0051085 | chaperone mediated protein folding requiring cofactor | 1.703054e-4 |
GO:0046485 | ether lipid metabolic process | 1.831437e-4 |
GO:0008217 | regulation of blood pressure | 1.879513e-4 |
GO:0030199 | collagen fibril organization | 1.904910e-4 |
GO:0035235 | ionotropic glutamate receptor signaling pathway | 1.937126e-4 |
GO:0045087 | innate immune response | 1.944529e-4 |
GO:0032825 | positive regulation of natural killer cell differentiation | 2.020387e-4 |
GO:0000305 | response to oxygen radical | 2.026207e-4 |
GO:0042220 | response to cocaine | 2.082116e-4 |
GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 2.099631e-4 |
GO:0060760 | positive regulation of response to cytokine stimulus | 2.139284e-4 |
GO:0034623 | cellular macromolecular complex disassembly | 2.154131e-4 |
GO:0000303 | response to superoxide | 2.213560e-4 |
GO:0051591 | response to cAMP | 2.228528e-4 |
GO:0002579 | positive regulation of antigen processing and presentation | 2.272928e-4 |
GO:0019438 | aromatic compound biosynthetic process | 2.278838e-4 |
GO:0009110 | vitamin biosynthetic process | 2.278838e-4 |
GO:0002685 | regulation of leukocyte migration | 2.287306e-4 |
GO:0033002 | muscle cell proliferation | 2.289608e-4 |
GO:0000045 | autophagic vacuole assembly | 2.307930e-4 |
GO:0032984 | macromolecular complex disassembly | 2.395823e-4 |
GO:0072593 | reactive oxygen species metabolic process | 2.424180e-4 |
GO:0042267 | natural killer cell mediated cytotoxicity | 2.452648e-4 |
GO:0002606 | positive regulation of dendritic cell antigen processing and presentation | 2.484415e-4 |
GO:0034341 | response to interferon-gamma | 2.511586e-4 |
GO:0071243 | cellular response to arsenic-containing substance | 2.541020e-4 |
GO:0050727 | regulation of inflammatory response | 2.542604e-4 |
GO:0033189 | response to vitamin A | 2.552259e-4 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 2.586398e-4 |
GO:0071506 | cellular response to mycophenolic acid | 2.586398e-4 |
GO:0070079 | histone H4-R3 demethylation | 2.589026e-4 |
GO:0018395 | peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine | 2.589026e-4 |
GO:0070078 | histone H3-R2 demethylation | 2.589026e-4 |
GO:0045807 | positive regulation of endocytosis | 2.590512e-4 |
GO:0071169 | establishment of protein localization to chromatin | 2.597231e-4 |
GO:0042594 | response to starvation | 2.745470e-4 |
GO:0045834 | positive regulation of lipid metabolic process | 2.913161e-4 |
GO:0015937 | coenzyme A biosynthetic process | 2.914398e-4 |
GO:0045103 | intermediate filament-based process | 2.927988e-4 |
GO:2000273 | positive regulation of receptor activity | 3.099464e-4 |
GO:0002687 | positive regulation of leukocyte migration | 3.137278e-4 |
GO:0032971 | regulation of muscle filament sliding | 3.138653e-4 |
GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol | 3.143999e-4 |
GO:0060343 | trabecula formation | 3.196078e-4 |
GO:0035691 | macrophage migration inhibitory factor signaling pathway | 3.253610e-4 |
GO:0000097 | sulfur amino acid biosynthetic process | 3.310116e-4 |
GO:0097022 | lymphocyte migration into lymph node | 3.318873e-4 |
GO:0072610 | interleukin-12 secretion | 3.318873e-4 |
GO:0043029 | T cell homeostasis | 3.379276e-4 |
GO:0034370 | triglyceride-rich lipoprotein particle remodeling | 3.421049e-4 |
GO:0030203 | glycosaminoglycan metabolic process | 3.488850e-4 |
GO:0071383 | cellular response to steroid hormone stimulus | 3.731854e-4 |
GO:0001676 | long-chain fatty acid metabolic process | 3.746704e-4 |
GO:0071299 | cellular response to vitamin A | 3.761261e-4 |
GO:0043588 | skin development | 3.950362e-4 |
GO:0002281 | macrophage activation involved in immune response | 4.010388e-4 |
GO:0010035 | response to inorganic substance | 4.036572e-4 |
GO:0007168 | receptor guanylyl cyclase signaling pathway | 4.078742e-4 |
GO:0048241 | epinephrine transport | 4.110993e-4 |
GO:0009396 | folic acid-containing compound biosynthetic process | 4.115941e-4 |
GO:0046628 | positive regulation of insulin receptor signaling pathway | 4.134147e-4 |
GO:0032350 | regulation of hormone metabolic process | 4.175254e-4 |
GO:0030048 | actin filament-based movement | 4.241068e-4 |
GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly | 4.272549e-4 |
GO:0031055 | chromatin remodeling at centromere | 4.272549e-4 |
GO:0018130 | heterocycle biosynthetic process | 4.287188e-4 |
GO:0042116 | macrophage activation | 4.398259e-4 |
GO:0070372 | regulation of ERK1 and ERK2 cascade | 4.429691e-4 |
GO:0042542 | response to hydrogen peroxide | 4.467353e-4 |
GO:0045980 | negative regulation of nucleotide metabolic process | 4.526885e-4 |
GO:0051414 | response to cortisol stimulus | 4.527824e-4 |
GO:0019430 | removal of superoxide radicals | 4.674077e-4 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 4.693759e-4 |
GO:0007354 | zygotic determination of anterior/posterior axis, embryo | 4.751876e-4 |
GO:0032615 | interleukin-12 production | 4.762906e-4 |
GO:0006665 | sphingolipid metabolic process | 4.786547e-4 |
GO:0002518 | lymphocyte chemotaxis across high endothelial venule | 4.859812e-4 |
GO:0051930 | regulation of sensory perception of pain | 4.943829e-4 |
GO:0060611 | mammary gland fat development | 5.222512e-4 |
GO:0070243 | regulation of thymocyte apoptosis | 5.298580e-4 |
GO:0006790 | sulfur compound metabolic process | 5.310036e-4 |
GO:0051588 | regulation of neurotransmitter transport | 5.416170e-4 |
GO:0006516 | glycoprotein catabolic process | 5.504049e-4 |
GO:0021548 | pons development | 5.581787e-4 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 5.611556e-4 |
GO:0042559 | pteridine-containing compound biosynthetic process | 5.625605e-4 |
GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan | 5.625605e-4 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 5.682692e-4 |
GO:0046626 | regulation of insulin receptor signaling pathway | 5.737095e-4 |
GO:0071385 | cellular response to glucocorticoid stimulus | 5.783721e-4 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 5.808759e-4 |
GO:0000096 | sulfur amino acid metabolic process | 5.834702e-4 |
GO:0042149 | cellular response to glucose starvation | 5.912922e-4 |
GO:0055085 | transmembrane transport | 5.957941e-4 |
GO:0031113 | regulation of microtubule polymerization | 5.964029e-4 |
GO:0002275 | myeloid cell activation involved in immune response | 6.079440e-4 |
GO:0061088 | regulation of sequestering of zinc ion | 6.155139e-4 |
GO:0019852 | L-ascorbic acid metabolic process | 6.212301e-4 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 6.232304e-4 |
GO:0048242 | epinephrine secretion | 6.232304e-4 |
GO:0002385 | mucosal immune response | 6.501838e-4 |
GO:0060024 | rhythmic synaptic transmission | 6.665909e-4 |
GO:0071549 | cellular response to dexamethasone stimulus | 6.727243e-4 |
GO:0097026 | dendritic cell dendrite assembly | 6.826528e-4 |
GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane | 6.826528e-4 |
GO:0031848 | protection from non-homologous end joining at telomere | 6.826528e-4 |
GO:0046903 | secretion | 6.847675e-4 |
GO:0045078 | positive regulation of interferon-gamma biosynthetic process | 6.907948e-4 |
GO:0044062 | regulation of excretion | 7.064994e-4 |
GO:0035621 | ER to Golgi ceramide transport | 7.074111e-4 |
GO:0031627 | telomeric loop formation | 7.074111e-4 |
GO:0006235 | dTTP biosynthetic process | 7.074111e-4 |
GO:0042304 | regulation of fatty acid biosynthetic process | 7.134519e-4 |
GO:0051336 | regulation of hydrolase activity | 7.254595e-4 |
GO:0071295 | cellular response to vitamin | 7.260603e-4 |
GO:0006415 | translational termination | 7.383848e-4 |
GO:0019221 | cytokine-mediated signaling pathway | 7.428615e-4 |
GO:0042744 | hydrogen peroxide catabolic process | 7.434428e-4 |
GO:0032103 | positive regulation of response to external stimulus | 7.452780e-4 |
GO:0070741 | response to interleukin-6 | 7.795748e-4 |
GO:0010046 | response to mycotoxin | 8.021241e-4 |
GO:0003094 | glomerular filtration | 8.021241e-4 |
GO:0019218 | regulation of steroid metabolic process | 8.049221e-4 |
GO:0006887 | exocytosis | 8.053024e-4 |
GO:0060709 | glycogen cell development involved in embryonic placenta development | 8.104445e-4 |
GO:0060376 | positive regulation of mast cell differentiation | 8.104445e-4 |
GO:0033135 | regulation of peptidyl-serine phosphorylation | 8.314404e-4 |
GO:0002830 | positive regulation of type 2 immune response | 8.371852e-4 |
GO:0001558 | regulation of cell growth | 8.374946e-4 |
GO:0071300 | cellular response to retinoic acid | 8.375513e-4 |
GO:0033129 | positive regulation of histone phosphorylation | 8.399874e-4 |
GO:0071732 | cellular response to nitric oxide | 8.683135e-4 |
GO:0007256 | activation of JNKK activity | 8.733044e-4 |
GO:0050771 | negative regulation of axonogenesis | 8.792345e-4 |
GO:0072522 | purine-containing compound biosynthetic process | 8.989312e-4 |
GO:0071347 | cellular response to interleukin-1 | 8.990940e-4 |
GO:0046928 | regulation of neurotransmitter secretion | 9.021208e-4 |
GO:0002920 | regulation of humoral immune response | 9.059669e-4 |
GO:0042908 | xenobiotic transport | 9.133679e-4 |
GO:0051188 | cofactor biosynthetic process | 9.210928e-4 |
GO:0034508 | centromere complex assembly | 9.416205e-4 |
GO:0006703 | estrogen biosynthetic process | 9.501878e-4 |
GO:0051955 | regulation of amino acid transport | 9.665010e-4 |
GO:0030818 | negative regulation of cAMP biosynthetic process | 9.798325e-4 |
GO:0006767 | water-soluble vitamin metabolic process | 9.844739e-4 |
GO:0051412 | response to corticosterone stimulus | 9.858382e-4 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 9.905498e-4 |
GO:0007217 | tachykinin receptor signaling pathway | 9.947661e-4 |
GO:0045218 | zonula adherens maintenance | 9.981908e-4 |
GO:0003229 | ventricular cardiac muscle tissue development | 1.053315e-3 |
GO:0060038 | cardiac muscle cell proliferation | 1.053692e-3 |
GO:0042249 | establishment of planar polarity of embryonic epithelium | 1.073047e-3 |
GO:0048678 | response to axon injury | 1.125677e-3 |
GO:0018149 | peptide cross-linking | 1.136893e-3 |
GO:0051572 | negative regulation of histone H3-K4 methylation | 1.144249e-3 |
GO:0006941 | striated muscle contraction | 1.145416e-3 |
GO:0051716 | cellular response to stimulus | 1.147124e-3 |
GO:0070293 | renal absorption | 1.185023e-3 |
GO:0010935 | regulation of macrophage cytokine production | 1.218575e-3 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 1.241238e-3 |
GO:0071675 | regulation of mononuclear cell migration | 1.256472e-3 |
GO:0051937 | catecholamine transport | 1.323693e-3 |
GO:0045123 | cellular extravasation | 1.331894e-3 |
GO:0050746 | regulation of lipoprotein metabolic process | 1.351787e-3 |
GO:0034220 | ion transmembrane transport | 1.374429e-3 |
GO:0006558 | L-phenylalanine metabolic process | 1.416302e-3 |
GO:0006040 | amino sugar metabolic process | 1.450383e-3 |
GO:0035249 | synaptic transmission, glutamatergic | 1.450383e-3 |
GO:0017085 | response to insecticide | 1.453764e-3 |
GO:0009108 | coenzyme biosynthetic process | 1.460565e-3 |
GO:0070498 | interleukin-1-mediated signaling pathway | 1.462640e-3 |
GO:0044106 | cellular amine metabolic process | 1.467040e-3 |
GO:0043409 | negative regulation of MAPKKK cascade | 1.478285e-3 |
GO:0055010 | ventricular cardiac muscle tissue morphogenesis | 1.491095e-3 |
GO:0010759 | positive regulation of macrophage chemotaxis | 1.516493e-3 |
GO:0006285 | base-excision repair, AP site formation | 1.518849e-3 |
GO:0001579 | medium-chain fatty acid transport | 1.518849e-3 |
GO:0014070 | response to organic cyclic compound | 1.536509e-3 |
GO:2000107 | negative regulation of leukocyte apoptosis | 1.553036e-3 |
GO:0042104 | positive regulation of activated T cell proliferation | 1.562045e-3 |
GO:0051532 | regulation of NFAT protein import into nucleus | 1.578311e-3 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 1.585316e-3 |
GO:0051289 | protein homotetramerization | 1.597221e-3 |
GO:0051179 | localization | 1.600355e-3 |
GO:0072302 | negative regulation of metanephric glomerular mesangial cell proliferation | 1.646581e-3 |
GO:2001076 | positive regulation of metanephric ureteric bud development | 1.646581e-3 |
GO:0007356 | thorax and anterior abdomen determination | 1.646581e-3 |
GO:0010872 | regulation of cholesterol esterification | 1.659916e-3 |
GO:0002251 | organ or tissue specific immune response | 1.664048e-3 |
GO:0006559 | L-phenylalanine catabolic process | 1.689128e-3 |
GO:0043086 | negative regulation of catalytic activity | 1.713126e-3 |
GO:2000412 | positive regulation of thymocyte migration | 1.723821e-3 |
GO:0048388 | endosomal lumen acidification | 1.723821e-3 |
GO:0009607 | response to biotic stimulus | 1.759590e-3 |
GO:0043270 | positive regulation of ion transport | 1.778056e-3 |
GO:0031116 | positive regulation of microtubule polymerization | 1.795743e-3 |
GO:0097028 | dendritic cell differentiation | 1.814134e-3 |
GO:0034122 | negative regulation of toll-like receptor signaling pathway | 1.860082e-3 |
GO:2000145 | regulation of cell motility | 1.867818e-3 |
GO:0006182 | cGMP biosynthetic process | 1.875326e-3 |
GO:0060555 | induction of necroptosis by extracellular signals | 1.884452e-3 |
GO:0097029 | mature dendritic cell differentiation | 1.901026e-3 |
GO:0042180 | cellular ketone metabolic process | 1.903138e-3 |
GO:0008643 | carbohydrate transport | 1.935374e-3 |
GO:0021670 | lateral ventricle development | 1.940844e-3 |
GO:0070071 | proton-transporting two-sector ATPase complex assembly | 1.968806e-3 |
GO:0030157 | pancreatic juice secretion | 1.968806e-3 |
GO:0032463 | negative regulation of protein homooligomerization | 1.968806e-3 |
GO:0015908 | fatty acid transport | 1.999847e-3 |
GO:0010614 | negative regulation of cardiac muscle hypertrophy | 2.008662e-3 |
GO:0051270 | regulation of cellular component movement | 2.040139e-3 |
GO:0046103 | inosine biosynthetic process | 2.051893e-3 |
GO:0045226 | extracellular polysaccharide biosynthetic process | 2.051893e-3 |
GO:0002077 | acrosome matrix dispersal | 2.051893e-3 |
GO:0006154 | adenosine catabolic process | 2.051893e-3 |
GO:0051881 | regulation of mitochondrial membrane potential | 2.071824e-3 |
GO:0042993 | positive regulation of transcription factor import into nucleus | 2.131007e-3 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 2.171298e-3 |
GO:0051597 | response to methylmercury | 2.218502e-3 |
GO:0006729 | tetrahydrobiopterin biosynthetic process | 2.242736e-3 |
GO:0019752 | carboxylic acid metabolic process | 2.264678e-3 |
GO:0051385 | response to mineralocorticoid stimulus | 2.269668e-3 |
GO:0045947 | negative regulation of translational initiation | 2.324207e-3 |
GO:0022616 | DNA strand elongation | 2.335460e-3 |
GO:0008215 | spermine metabolic process | 2.335460e-3 |
GO:0044282 | small molecule catabolic process | 2.345707e-3 |
GO:0006047 | UDP-N-acetylglucosamine metabolic process | 2.360337e-3 |
GO:0016125 | sterol metabolic process | 2.368829e-3 |
GO:0035272 | exocrine system development | 2.375194e-3 |
GO:0010876 | lipid localization | 2.375801e-3 |
GO:0071371 | cellular response to gonadotropin stimulus | 2.399644e-3 |
GO:0072284 | metanephric S-shaped body morphogenesis | 2.407412e-3 |
GO:0072278 | metanephric comma-shaped body morphogenesis | 2.407412e-3 |
GO:2000467 | positive regulation of glycogen (starch) synthase activity | 2.440760e-3 |
GO:0002443 | leukocyte mediated immunity | 2.441036e-3 |
GO:0042558 | pteridine-containing compound metabolic process | 2.499260e-3 |
GO:0008015 | blood circulation | 2.505752e-3 |
GO:0008203 | cholesterol metabolic process | 2.552001e-3 |
GO:0051569 | regulation of histone H3-K4 methylation | 2.552534e-3 |
GO:0033273 | response to vitamin | 2.552654e-3 |
GO:0030300 | regulation of intestinal cholesterol absorption | 2.579509e-3 |
GO:0006082 | organic acid metabolic process | 2.596353e-3 |
GO:0050878 | regulation of body fluid levels | 2.610164e-3 |
GO:0002577 | regulation of antigen processing and presentation | 2.618655e-3 |
GO:0050766 | positive regulation of phagocytosis | 2.625710e-3 |
GO:0006164 | purine nucleotide biosynthetic process | 2.638678e-3 |
GO:0072676 | lymphocyte migration | 2.664607e-3 |
GO:0070430 | positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway | 2.747757e-3 |
GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway | 2.747757e-3 |
GO:0046670 | positive regulation of retinal cell programmed cell death | 2.747757e-3 |
GO:0071624 | positive regulation of granulocyte chemotaxis | 2.747757e-3 |
GO:0070535 | histone H2A K63-linked ubiquitination | 2.747757e-3 |
GO:0016142 | O-glycoside catabolic process | 2.747757e-3 |
GO:0002525 | acute inflammatory response to non-antigenic stimulus | 2.747757e-3 |
GO:0032707 | negative regulation of interleukin-23 production | 2.747757e-3 |
GO:0045362 | positive regulation of interleukin-1 biosynthetic process | 2.747757e-3 |
GO:0032526 | response to retinoic acid | 2.765082e-3 |
GO:0060351 | cartilage development involved in endochondral bone morphogenesis | 2.767950e-3 |
GO:0001961 | positive regulation of cytokine-mediated signaling pathway | 2.805320e-3 |
GO:2000300 | regulation of synaptic vesicle exocytosis | 2.817501e-3 |
GO:0006811 | ion transport | 2.844903e-3 |
GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline | 2.844930e-3 |
GO:0006833 | water transport | 2.853065e-3 |
GO:0042487 | regulation of odontogenesis of dentine-containing tooth | 2.874535e-3 |
GO:0006072 | glycerol-3-phosphate metabolic process | 2.874535e-3 |
GO:0034379 | very-low-density lipoprotein particle assembly | 2.874535e-3 |
GO:0035121 | tail morphogenesis | 2.898326e-3 |
GO:0006869 | lipid transport | 2.909662e-3 |
GO:0030204 | chondroitin sulfate metabolic process | 3.000838e-3 |
GO:0042987 | amyloid precursor protein catabolic process | 3.024029e-3 |
GO:0071474 | cellular hyperosmotic response | 3.108722e-3 |
GO:0070836 | caveola assembly | 3.108722e-3 |
GO:0002352 | B cell negative selection | 3.108722e-3 |
GO:0019240 | citrulline biosynthetic process | 3.108722e-3 |
GO:0032682 | negative regulation of chemokine production | 3.108722e-3 |
GO:0010758 | regulation of macrophage chemotaxis | 3.143140e-3 |
GO:0006405 | RNA export from nucleus | 3.241759e-3 |
GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway | 3.303636e-3 |
GO:0006979 | response to oxidative stress | 3.335650e-3 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 3.358291e-3 |
GO:0071168 | protein localization to chromatin | 3.358630e-3 |
GO:0051127 | positive regulation of actin nucleation | 3.358630e-3 |
GO:0021578 | hindbrain maturation | 3.365060e-3 |
GO:0002906 | negative regulation of mature B cell apoptosis | 3.431094e-3 |
GO:0046146 | tetrahydrobiopterin metabolic process | 3.436020e-3 |
GO:0060627 | regulation of vesicle-mediated transport | 3.447841e-3 |
GO:0055017 | cardiac muscle tissue growth | 3.483129e-3 |
GO:0033194 | response to hydroperoxide | 3.483129e-3 |
GO:0051293 | establishment of spindle localization | 3.495229e-3 |
GO:0002432 | granuloma formation | 3.549007e-3 |
GO:0042044 | fluid transport | 3.576608e-3 |
GO:0006003 | fructose 2,6-bisphosphate metabolic process | 3.583079e-3 |
GO:0034614 | cellular response to reactive oxygen species | 3.606441e-3 |
GO:0045649 | regulation of macrophage differentiation | 3.659779e-3 |
GO:0051453 | regulation of intracellular pH | 3.719927e-3 |
GO:0001833 | inner cell mass cell proliferation | 3.724567e-3 |
GO:0010936 | negative regulation of macrophage cytokine production | 3.785538e-3 |
GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation | 3.797467e-3 |
GO:0030334 | regulation of cell migration | 3.804236e-3 |
GO:0046068 | cGMP metabolic process | 3.869795e-3 |
GO:0055009 | atrial cardiac muscle tissue morphogenesis | 3.921559e-3 |
GO:0061383 | trabecula morphogenesis | 3.952684e-3 |
GO:0051291 | protein heterooligomerization | 3.958948e-3 |
GO:0046502 | uroporphyrinogen III metabolic process | 4.008693e-3 |
GO:0018101 | peptidyl-citrulline biosynthetic process from peptidyl-arginine | 4.008693e-3 |
GO:0033133 | positive regulation of glucokinase activity | 4.109963e-3 |
GO:0006116 | NADH oxidation | 4.109963e-3 |
GO:0006572 | tyrosine catabolic process | 4.109963e-3 |
GO:0045931 | positive regulation of mitotic cell cycle | 4.131609e-3 |
GO:0044255 | cellular lipid metabolic process | 4.199828e-3 |
GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process | 4.355189e-3 |
GO:0043610 | regulation of carbohydrate utilization | 4.355189e-3 |
GO:0060381 | positive regulation of single-stranded telomeric DNA binding | 4.355189e-3 |
GO:0002638 | negative regulation of immunoglobulin production | 4.355189e-3 |
GO:0016140 | O-glycoside metabolic process | 4.355189e-3 |
GO:0006409 | tRNA export from nucleus | 4.355189e-3 |
GO:0001811 | negative regulation of type I hypersensitivity | 4.355189e-3 |
GO:0032074 | negative regulation of nuclease activity | 4.459311e-3 |
GO:0045110 | intermediate filament bundle assembly | 4.459311e-3 |
GO:0034635 | glutathione transport | 4.459311e-3 |
GO:0010625 | positive regulation of Schwann cell proliferation | 4.459311e-3 |
GO:0009817 | defense response to fungus, incompatible interaction | 4.459311e-3 |
GO:0051704 | multi-organism process | 4.543583e-3 |
GO:0035634 | response to stilbenoid | 4.557430e-3 |
GO:0009612 | response to mechanical stimulus | 4.557933e-3 |
GO:0050764 | regulation of phagocytosis | 4.613998e-3 |
GO:0009620 | response to fungus | 4.617452e-3 |
GO:0006629 | lipid metabolic process | 4.618260e-3 |
GO:0032321 | positive regulation of Rho GTPase activity | 4.640360e-3 |
GO:0051973 | positive regulation of telomerase activity | 4.660359e-3 |
GO:2000286 | receptor internalization involved in canonical Wnt receptor signaling pathway | 4.660359e-3 |
GO:0051050 | positive regulation of transport | 4.690078e-3 |
GO:0007005 | mitochondrion organization | 4.752937e-3 |
GO:0030010 | establishment of cell polarity | 4.761740e-3 |
GO:0090026 | positive regulation of monocyte chemotaxis | 4.771963e-3 |
GO:0090208 | positive regulation of triglyceride metabolic process | 4.776925e-3 |